Austrian pharma company alleges arbitral fraud
An Austrian pharmaceuticals company has asked a US court to grant discovery to support criminal allegations that its Taiwanese partner has made fraudulent statements in two ICC arbitrations arising from a multibillion-euro dispute over a blood cancer drug.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access